Residual Component Detection

Safeguarding Biotherapeutic Purity from R&D to Release

In the highly regulated world of biopharmaceutical manufacturing, residual contaminants – like host cell DNA, plasmid fragments, mycoplasma and process enzymes – pose critical risks to product safety, efficacy, and regulatory compliance. Undetected impurities can trigger costly batch failures, delayed timelines, and patient safety concerns.

Here we provide a residual detection products cover various applications related to process-related residue detection for biopharmaceuticals, including antibody drugs, cell and gene therapies (CGT), vaccines.

Why trust our kits?

Bioactivity graph

Validated Performance

Stringent batch testing and release, comprehensive performance validations.

Traceable Quality

Manufactured under ISO 13485 for consistent performance and risk control.

Expert Support

Dedicated scientists for assay troubleshooting

Accelerate Your Quality Testing Workflow Today!

support@kactusbio.us

All kits for research use only.